View Information Collection Request (ICR) Package

OMB Control No: 0920-1282	ICR Reference No: 202301-0920-015
Status: Active	Previous ICR Reference No: 201907-0920-007
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-19IJ
Title: The Performance Measures Project: Improving Performance Measurement and Monitoring by CDC Programs
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 06/13/2023
Retrieve Notice of Action (NOA)	Date Received in OIRA: 01/31/2023
Terms of Clearance: Prior to the renewal of the 0920-1282 umbrella generic, CDC will consult with the desk officer to develop a plan for the restructuring of existing instruments, which span multiple programs. Moving forward, OMB will not approve multi-program instruments through this generic unless otherwise agreed upon prior to submission. Gen ICs that are methodologically complex, that could benefit from public comment, or that could otherwise necessitate more in-depth review may need to be resubmitted as new ICRs. GenICs under this generic are approved so long as the umbrella generic is active; for GenICs requiring data collection beyond a three-year approval, CDC will need to renew the umbrella generic. Revisions to GenICs should be submitted as change requests. CDC should complete an update to the Completion and Carryover Summary document with each GenIC submission and/or renewal of the umbrella generic. For programs requesting a change in data collection frequency (other than annual), CDC will note this in the GenIC Request Template and provide justification. Previous Terms of Clearance also continue: Approved consistent with the understanding that CDC will submit individual collections under this generic clearance to OMB. These submissions will include the actual study instruments along with a completed template describing the performance metrics used. Approved consistent with the understanding that the agency will use this generic specifically for program improvement and accountability associated with cooperative agreements and grants. CDC will send OMB an annual report summarizing the number of hours used, as well as the nature and results of the activities completed under this clearance.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	06/30/2026	36 Months From Approved	06/30/2023
Responses	11,826	0	2,625
Time Burden (Hours)	291,147	0	105,000
Cost Burden (Dollars)	0	0	3,923,850

Abstract: The purpose of this generic data collection is to: 1) help CDC programs and their recipients develop strong performance measurement systems and practices; 2) define and operationalize priority performance measures; and 3) establish common data collection and reporting expectations. Data will enable the accurate, reliable, uniform and timely submission of recipients' progress. Changes described in this Revision include an increase in capacity (burden) to accommodate expanded eligibility and usage of the generic by a variety of programs at CDC/ATSDR, and a modified project template that will accommodate a variety of data collection schedules (annual, semi-annual, quarterly, multi-year, etc.).

Authorizing Statute(s): US Code: 42 USC 45 CFR 75.342 Name of Law: Monitoring and reporting program performance

Citations for New Statutory Requirements: None

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	87 FR 44121	07/25/2022
30-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 2928	01/18/2023
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	11,826	2,625	9,201
Annual Time Burden (Hours)	291,147	105,000	186,147
Annual Cost Burden (Dollars)	0	3,923,850	-3,923,850

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: CDC requests an increase in burden and responses to accommodate expanded eligibility criteria for participation in the PMP and anticipated increase in usage of this generic by CDC/ATSDR programs. In addition, many programs are funded for multiple years and will need to collect performance data for the entire period of performance. Note that the change in the total cost burden appears to be very large. However, the change in total cost burden is associated with the change in accounting method. In the past, CDC reported the cost burden for each IC as the wage-equivalents that appear in Section 12.B of the supporting statement. Consistent with the rest of HHS, CDC is now reporting the total from Section 13 in the "burden cost" field for each IC. Section 13 covers nonwage costs (e.g., equipment). As such, costs associated with these ICs are now "zero."

Annual Cost to Federal Government: $117,154

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Yes

Agency Contact: Renita Macaluso 770 488-6458 arp5@cdc.gov

View Generic ICR - OIRA Conclusion